| scholarly article | Q13442814 |
| P50 | author | Matteo Bassetti | Q88607142 |
| P2093 | author name string | Alessio Farcomeni | |
| Marco Falcone | |||
| Alessandro Russo | |||
| Francesco Menichetti | |||
| Enrico Tagliaferri | |||
| Elena Graziano | |||
| Alessandro Leonildi | |||
| Giusy Tiseo | |||
| Simona Barnini | |||
| Cesira Giordano | |||
| Elia Nencini | |||
| P2860 | cites work | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768286 |
| APACHE II: a severity of disease classification system | Q29547729 | ||
| The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine | Q29618869 | ||
| Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. | Q34424217 | ||
| Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies | Q34869292 | ||
| Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia | Q34999856 | ||
| Causes of death and determinants of outcome in critically ill patients | Q35629826 | ||
| Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections. | Q38677017 | ||
| Time to Treatment and Mortality during Mandated Emergency Care for Sepsis | Q38772690 | ||
| Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections | Q38901844 | ||
| Management of KPC-Producing Klebsiella pneumoniae Infections. | Q40046893 | ||
| Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems. | Q40192475 | ||
| Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States | Q40342728 | ||
| Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis | Q40786799 | ||
| Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. | Q40802659 | ||
| Evaluation of the RAPIDEC® CARBA NP, the Rapid CARB Screen® and the Carba NP test for biochemical detection of carbapenemase-producing Enterobacteriaceae | Q41060492 | ||
| Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes. | Q41430437 | ||
| The early antibiotic therapy in septic patients--milestone or sticking point? | Q41489445 | ||
| Colistin vs. Ceftazidime-avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae | Q41986995 | ||
| Colistin distribution in the peritoneal fluid of a patient with severe peritonitis. | Q43219296 | ||
| Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study | Q43288550 | ||
| Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program | Q46444641 | ||
| Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. | Q48540306 | ||
| Risks of infection and mortality among patients colonized with KPC-producing Klebsiella pneumoniae: validation of scores and proposal for management. | Q50068803 | ||
| A Prospective Evaluation of Two Rapid Phenotypical Antimicrobial Susceptibility Technologies for the Diagnostic Stewardship of Sepsis. | Q55004497 | ||
| Impact of Combination Therapy Monotherapy on Mortality from Carbapenem-Resistant Enterobacteriaceae Bacteremia: A Retrospective Observational Study from a Chinese Network | Q57800936 | ||
| Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis | Q58611181 | ||
| Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy | Q64131374 | ||
| Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections | Q64135161 | ||
| Rapid Detection of Carbapenemase Production Directly from Blood Culture by Colorimetric Methods: Evaluation in a Routine Microbiology Laboratory. | Q64892578 | ||
| Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections | Q78524086 | ||
| Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock | Q83177700 | ||
| Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumannii | Q90024037 | ||
| Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study | Q90569714 | ||
| Blood Culture Turnaround Time in U.S. Acute Care Hospitals and Implications for Laboratory Process Optimization | Q91088356 | ||
| Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia | Q91313770 | ||
| Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial | Q91518721 | ||
| Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment | Q91652276 | ||
| RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections | Q92542100 | ||
| The inoculum effect of Escherichia coli expressing mcr-1 or not on colistin activity in a murine model of peritonitis | Q93170157 | ||
| P433 | issue | 1 | |
| P921 | main subject | Klebsiella pneumoniae | Q132592 |
| P304 | page(s) | 29 | |
| P577 | publication date | 2020-01-30 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae | |
| P478 | volume | 24 |
Search more.